NAD+ fatigue claims on TikTok: what the science says

What did @coachcam.peps3 actually say?

The creator argues that NAD+ causes fatigue in some people for four main reasons: damaged Complex I of the electron transport chain, methyl pool depletion, insufficient caloric and macronutrient supply to meet increased energy demand, and a misunderstanding that NAD+ prioritizes repair over energy output in compromised systems.

The framing is more mechanistic than most supplement content on TikTok. He describes NAD+ as "a co-enzyme that plays a role in many biological processes," not a direct energy source. He recommends SS-31, CoQ10, methylated B vitamins, and trimethylglycine (TMG) as supportive co-interventions. He's careful to add a disclaimer that this is "for educational and research purposes only." The overall argument is that NAD+ amplifies whatever system it encounters, broken or functional, and that lifestyle foundation matters more than the supplement itself.

Does the science back this up?

Mostly, yes, with some important caveats. The core biochemistry here is real, though the confidence level varies by claim. The electron transport chain mechanism and methyl donor depletion are genuinely supported by research. The "repair before energy" framing is plausible but not as well-established as the video implies.

On Complex I: oxidative damage to NADH dehydrogenase (Complex I) is well-documented in conditions like chronic fatigue syndrome, aging, and inflammatory states. A 2019 review by Hargreaves and Murphy in Redox Biology confirmed that dysfunctional Complex I increases superoxide production rather than ATP yield. The logic that flooding a damaged Complex I with electrons worsens oxidative stress rather than producing energy is biochemically sound.

On methyl depletion: nicotinamide methyltransferase (NNMT) does consume S-adenosylmethionine (SAM) to excrete nicotinamide, and this mechanism has been shown in animal models to reduce methyl availability. Canto et al. (2012, Cell Metabolism) and follow-up work by Trammell et al. (2016, Nature Communications) support this pathway. The recommendation to co-supplement with TMG or methylated B vitamins is consistent with current practice in functional medicine contexts, though human trial evidence remains thin.

What did they get wrong (or right)?

They got the core biochemistry largely right. Where things get shakier is in the clinical extrapolation. The "repair before energy" concept, while intuitive, lacks the direct human evidence the creator implies. It's a reasonable hypothesis drawn from sirtuin and PARP activation research, but presenting it as an established mechanism overstates the literature.

The SS-31 recommendation deserves scrutiny. SS-31 (elamipretide) is a mitochondria-targeted peptide studied primarily in heart failure and age-related muscle decline. Szeto et al. (2014, Journal of Cardiovascular Pharmacology) showed Complex I protection in animal models, but human data for SS-31 as a general NAD+ adjunct is essentially nonexistent. Recommending it casually in a TikTok video as one of "my favorite things to repair Complex I" is a stretch that conflates promising preclinical data with established clinical use.

The sirtuin section is also simplified to the point of being slightly misleading. He says NAD+ "red lines mitochondrial functions," which is vague enough to be harmless but imprecise. Sirtuins require NAD+ as a substrate, but their activation depends on NAD+/NADH ratio, not absolute NAD+ levels alone (Houtkooper et al., 2010, Nature Reviews Molecular Cell Biology).

On balance, the video is more accurate than most supplement content in this space. The disclaimer is present. The mechanism is directionally correct. The oversimplifications are frustrating but not dangerous.

What should you actually know?

NAD+ precursors like NMN and NR are among the most studied longevity supplements, but the human trial data is still maturing. The fatigue side effect is real and underreported, and the mechanistic explanations offered here are reasonable starting points for understanding why.

What the video doesn't say: the dose and delivery route matter considerably. IV NAD+ infusions produce far more pronounced effects, including fatigue, nausea, and chest tightness, than oral NMN or NR. Most of the dramatic "Complex I flooding" scenarios are more relevant to high-dose IV administration than to standard oral supplementation. That context is missing here.

Also missing: individual variation in NNMT activity is genetic. Some people methylate nicotinamide faster than others, meaning methyl depletion risk is not uniform. Before loading up on TMG based on a TikTok, it is worth knowing that excess methyl donors carry their own risks, including overmethylation symptoms like anxiety and insomnia in sensitive individuals.

If you are experiencing fatigue on NAD+ precursors, the practical checklist is reasonable: check sleep, check caloric intake, consider methylation support, and talk to a clinician before adding peptides like SS-31 to the stack.